PepGen (PEPG) Cash from Financing Activities (2021 - 2026)

PepGen (PEPG) posted Cash from Financing Activities of $1.5 million for Q1 2026, up 987.72% sequentially from -$171000.0 in Q4 2025.

PepGen (PEPG) Cash from Financing Activities (2021 - 2026) Analysis & Trends

PepGen has reported Cash from Financing Activities for 6 years, with the latest figure at $1.5 million in Q1 2026.

  • Quarterly Cash from Financing Activities changed N/A year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $109.5 million (up 6044.61% YoY) and the FY2025 annual result came in at $108.0 million, up 21.67% from the prior year.
  • Cash from Financing Activities advanced to $1.5 million in Q1 2026 per PEPG's latest filing, from -$171000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $113.4 million in Q2 2022 and troughed at -$1.4 million in Q3 2022.
  • A 5-year average of $19.4 million and a median of $129000.0 in 2023 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 66797.69% in 2024, then plunged 233.59% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $217000.0 in 2022, then tumbled by 88.02% to $26000.0 in 2023, then jumped by 392.31% to $128000.0 in 2024, then slumped by 233.59% to -$171000.0 in 2025, then soared by 987.72% to $1.5 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $1.5 million, -$171000.0, and $108.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.42 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -6.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -207,909.22
7 Royalty Pharma 33.72 Bn 35.84 Bn - -273.15 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 36.24 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 27.18 Mn
10 PepGen 207.09 Mn 207.09 Mn - -65,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -65,000.00
Jun 30, 2026 -65,000.00
Mar 31, 2026 1.52 Mn
Mar 31, 2026 1.52 Mn
Dec 31, 2025 -171,000.00
Dec 31, 2025 -171,000.00
Sep 30, 2025 108.05 Mn
Sep 30, 2025 108.05 Mn
Jun 30, 2025 98,000.00
Jun 30, 2025 98,000.00
Dec 31, 2024 128,000.00
Dec 31, 2024 128,000.00
Sep 30, 2024 327,000.00
Sep 30, 2024 327,000.00
Jun 30, 2024 1.33 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 86.97 Mn
Mar 31, 2024 86.97 Mn
Dec 31, 2023 26,000.00
Dec 31, 2023 26,000.00